MERLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 611
EU - Europa 380
AS - Asia 331
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.324
Nazione #
US - Stati Uniti d'America 604
CN - Cina 285
IE - Irlanda 177
FI - Finlandia 61
UA - Ucraina 35
DE - Germania 29
IT - Italia 28
IN - India 21
SE - Svezia 19
SG - Singapore 19
GB - Regno Unito 11
FR - Francia 9
CA - Canada 7
BE - Belgio 4
JP - Giappone 3
RU - Federazione Russa 2
TR - Turchia 2
AU - Australia 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
Totale 1.324
Città #
Dublin 174
Chandler 151
Nanjing 71
Jacksonville 64
Beijing 54
Boardman 46
Ashburn 43
Nanchang 31
Ann Arbor 26
Helsinki 25
Princeton 25
Wilmington 25
Lawrence 24
Changsha 23
Shanghai 22
Pune 20
Medford 16
Shenyang 16
Hebei 15
Jiaxing 14
New York 14
Singapore 13
Los Angeles 12
Tianjin 12
Milan 9
Woodbridge 8
Pavia 7
Toronto 5
Brussels 4
Hangzhou 4
Norwalk 4
Cork 3
Tokyo 3
Fairfield 2
Falkenstein 2
Guangzhou 2
Houston 2
Jinan 2
Ningbo 2
San Francisco 2
Seattle 2
Washington 2
Zhengzhou 2
Athens 1
Auburn Hills 1
Baoding 1
Baotou 1
Canberra 1
Chengdu 1
Clifton 1
Dearborn 1
Des Moines 1
Kunming 1
Lanzhou 1
Markham 1
Monmouth Junction 1
Olomouc 1
Oslo 1
Redwood City 1
Saint Petersburg 1
San Jose 1
Targu 1
Tomsk 1
Verona 1
Wuhan 1
Xiangtan 1
Totale 1.026
Nome #
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 93
High resolution genome-wide array-comparative genomic hybridization in splenic marginal zone B-cell lymphoma 74
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 71
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. 67
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 67
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. 65
Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia 59
Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma 57
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy 55
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms 55
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi. 54
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 54
The NOTCH pathway is recurrently mutated in diffuse large B cell lymphoma associated with hepatitis C virus infection. 54
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. 53
Everolimus in diffuse large B-cell lymphomas 53
Antiviral therapies for managing viral hepatitis in lymphoma patients 52
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 50
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project. 49
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 48
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 48
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 47
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. 35
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. 30
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 22
null 21
Rituximab maintenance in follicular lymphoma patients 19
Pre-Treatment with Bendamustine Does Not Affect Stem Cell Mobilization in Patients with Indolent Non-Hodgkin Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi 14
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms 10
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi 7
Totale 1.383
Categoria #
all - tutte 6.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020100 0 0 0 7 1 7 6 14 6 43 15 1
2020/2021104 10 7 2 8 7 8 1 20 15 14 9 3
2021/2022103 3 2 4 0 5 1 0 9 4 1 16 58
2022/2023441 37 44 5 26 43 37 0 19 204 1 15 10
2023/2024220 19 40 10 12 13 62 4 15 2 12 17 14
2024/202558 11 32 15 0 0 0 0 0 0 0 0 0
Totale 1.383